NovoRapid 100 units/ml solution for injection in vial clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
The effect of empagliflozin on peripheral microvascular dysfunction in heart failure with preserved ejection fraction
This study for people with a type of heart failure called 'heart failure with preserved ejection fraction' is looking at how a medicine called empagliflozin affects tiny blood vessels in the skin. We want to see if it improves blood flow.
For: Heart failure with preserved ejection fractionNetherlands - Ongoing, recruitingTherapeutic use (Phase IV)
InSaKa trial: Insulin dextrose infusion versus nebulized salbutamol versus combination of salbutamol and insulin dextrose in acute hyperkalemia: a randomized clinical trial
This study, called InSaKa, is looking at the best way to treat a condition called hyperkalemia, where there's too much potassium in the blood. It compares different treatments, including insulin and dextrose, a breathing treatment called salbutamol, and a combination of both, to see which works best and is safest.
For: HyperkalemiaFrance - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A single-center pilot study to establish a novel hypoglycemic clamp procedure to assess the time to spontaneous recovery from hypoglycemia in people with and without diabetes
This study looks at how people with and without type 2 diabetes recover from low blood sugar. Researchers use a special method to see how much insulin is needed to lower blood sugar and how long it takes for it to naturally return to normal after becoming very low.
For: Type 2 Diabetes MellitusAustria